GILEAD SCIENCES INC's ticker is and the CUSIP is 375558903. A total of 10 filers reported holding GILEAD SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,818,936 | +161.8% | 184,400 | +169.2% | 0.00% | +100.0% |
| Q2 2023 | $5,279,295 | -49.0% | 68,500 | -45.1% | 0.00% | 0.0% |
| Q1 2023 | $10,346,000 | +78154.3% | 124,700 | -19.0% | 0.00% | -50.0% |
| Q4 2022 | $13,221 | -99.8% | 154,000 | +38.6% | 0.00% | +100.0% |
| Q3 2022 | $6,854,000 | -0.2% | 111,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,867,000 | -55.9% | 111,100 | -57.6% | 0.00% | -50.0% |
| Q1 2022 | $15,588,000 | -61.4% | 262,200 | -52.8% | 0.00% | -60.0% |
| Q4 2021 | $40,357,000 | +270.6% | 555,800 | +256.5% | 0.01% | +400.0% |
| Q3 2021 | $10,890,000 | -58.4% | 155,900 | -59.0% | 0.00% | -66.7% |
| Q2 2021 | $26,167,000 | +700.2% | 380,000 | +651.0% | 0.00% | – |
| Q1 2021 | $3,270,000 | -85.9% | 50,600 | -87.3% | 0.00% | -100.0% |
| Q4 2020 | $23,252,000 | -38.3% | 399,100 | -34.2% | 0.00% | -50.0% |
| Q3 2020 | $37,682,000 | +179.9% | 606,800 | +246.7% | 0.01% | +100.0% |
| Q2 2020 | $13,465,000 | -52.2% | 175,000 | -53.5% | 0.00% | -57.1% |
| Q1 2020 | $28,162,000 | +24.8% | 376,700 | +8.4% | 0.01% | +75.0% |
| Q4 2019 | $22,574,000 | +304.8% | 347,400 | +294.8% | 0.00% | +300.0% |
| Q3 2019 | $5,577,000 | -55.8% | 88,000 | -53.2% | 0.00% | -50.0% |
| Q2 2019 | $12,611,000 | -64.0% | 188,000 | -65.1% | 0.00% | -71.4% |
| Q1 2019 | $35,060,000 | +157.6% | 539,300 | +147.8% | 0.01% | +133.3% |
| Q4 2018 | $13,611,000 | -64.2% | 217,600 | -55.8% | 0.00% | -57.1% |
| Q3 2018 | $38,041,000 | +71.7% | 492,700 | +57.6% | 0.01% | +40.0% |
| Q2 2018 | $22,152,000 | +19.6% | 312,700 | +27.3% | 0.01% | +25.0% |
| Q1 2018 | $18,523,000 | -43.5% | 245,700 | -46.3% | 0.00% | -42.9% |
| Q4 2017 | $32,782,000 | -71.8% | 457,600 | -68.2% | 0.01% | -73.1% |
| Q3 2017 | $116,316,000 | +569.7% | 1,437,600 | +485.8% | 0.03% | +550.0% |
| Q2 2017 | $17,369,000 | +6.6% | 245,400 | +2.2% | 0.00% | 0.0% |
| Q1 2017 | $16,301,000 | +124.7% | 240,000 | +136.9% | 0.00% | +100.0% |
| Q4 2016 | $7,254,000 | -44.2% | 101,300 | -38.4% | 0.00% | -33.3% |
| Q3 2016 | $13,007,000 | +81.3% | 164,400 | +91.2% | 0.00% | +50.0% |
| Q2 2016 | $7,174,000 | -77.4% | 86,000 | -75.1% | 0.00% | -75.0% |
| Q1 2016 | $31,692,000 | -4.3% | 345,000 | +5.4% | 0.01% | 0.0% |
| Q4 2015 | $33,130,000 | +218.6% | 327,400 | +209.2% | 0.01% | +166.7% |
| Q3 2015 | $10,398,000 | – | 105,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 963,700 | $67,314,000 | 1.98% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $10,478,000 | 0.32% |
| Capital Markets Trading UK LLP | 245,200 | $17,394,000 | 0.23% |
| GROUP ONE TRADING, L.P. | 1,338,800 | $93,515,000 | 0.10% |
| SIMPLEX TRADING, LLC | 757,000 | $52,331,000 | 0.05% |
| Marathon Trading Investment Management LLC | 4,000 | $279,000 | 0.02% |
| Maven Securities LTD | 5,400 | $377,000 | 0.01% |
| Allianz Asset Management GmbH | 70,900 | $4,952,000 | 0.00% |
| JPMORGAN CHASE & CO | 155,900 | $10,890,000 | 0.00% |
| CIBC WORLD MARKETS CORP | 2,000 | $140,000 | 0.00% |